SOLICITATION NOTICE
65 -- DoD Uniform Formulary Blanket Purchase Agreement/Additional Discount Program - Appendix Overactive Bladder Agents - Appendix Ophthalmic 1 Agents Antihistamine Mast Cell - Appendix Pulmonary Miscellaneous - RFQ HT9402-17-Q-0004 - Utilization Data Set
- Notice Date
- 2/14/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- Other Defense Agencies, Defense Health Agency, Contracting Office - Aurora, 16401 E. CenterTech Pkwy., Aurora, Colorado, 80011, United States
- ZIP Code
- 80011
- Solicitation Number
- HT9402-17-Q-0004
- Point of Contact
- Keith Boulware, Phone: 303-676-3911, ,
- E-Mail Address
-
keith.boulware.ctr@mail.mil, dha.detrick.cod-a.mbx.dha-uf-bpa-official@mail.mil
(keith.boulware.ctr@mail.mil, dha.detrick.cod-a.mbx.dha-uf-bpa-official@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- Utilization Data Set RFQ HT9402-17-Q-0004 Appendix Pulmonary Miscellaneous Appendix Ophthalmic 1 Agents Antihistamine Mast Cell Appendix Overactive Bladder Agents The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. (Required) The next quarterly P&T Committee Meeting Date is May 2017. Go to http://www.health.mil/About-MHS/Other-MHS-Organizations/DoD-Pharmacy-and-Therapeutics-Committee/RFQ-Information/ webpage and go to the appropriate DoD Committee Meeting date. On this page manufacturers will find information on the drug classes, specific drugs, how to register and how to schedule a clinical presentation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/249251e0ce36ff50e7233db2715a041d)
- Place of Performance
- Address: United States
- Record
- SN04401547-W 20170216/170214234256-249251e0ce36ff50e7233db2715a041d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |